Illumina INC:1107104 [21-003946] - the genomic technology section within niams requests the purchase of sequencing reagent kits for our illumina novaseq 6000 and nextseq 550. These kits are…
Ended Awarded
- Contract number
- 75N92B21F02005
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $247,445
Award facts
- Contract value 100% obligated
- $247,444.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm-fixed-price delivery order contract worth $247,444.82 to Illumina, Inc. to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 550 sequencing instruments. The contract has a completion date of September 2, 2025. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has previously provided equipment and supplies to support sequencing and analysis needs across various federal agencies, including the NIH, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs. This contract does not have a set-aside designation.
Description
Illumina INC:1107104 [21-003946] - the genomic technology section within niams requests the purchase of sequencing reagent kits for our illumina novaseq 6000 and nextseq 550. These kits are extremely essential to continue the sequencing operation of
Quick answers
Who was awarded contract 75N92B21F02005?
75N92B21F02005 was awarded to Illumina, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on July 29, 2021.
How much is contract 75N92B21F02005 worth?
The government has obligated $247,445 on 75N92B21F02005.
Is contract 75N92B21F02005 an order under another contract?
Yes. 75N92B21F02005 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92B21F02005 competed?
The extent of competition for 75N92B21F02005 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award